Oxcarbazepine
- Product NDC
- 70518-3237
- Requested package NDC
- 70518-3237-0
- 11-digit product format
- 705183237
- Labeler code
- 70518
- Product ID
- 70518-3237_4b04e14b-81c3-42d7-e063-6394a90aaeaa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxcarbazepine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077802
- Marketing category
- ANDA
- Marketing start
- 2021-10-13
- Substance
- OXCARBAZEPINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-3237 | 70518-3237-0 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077802-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2007-10-09 | |
| A077802-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2007-10-09 | |
| A077802-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2007-10-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077802-001 | AB |
| A077802-002 | AB |
| A077802-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077802-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | AB | 2007-10-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077802-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | AB | 2007-10-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077802-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | AB | 2007-10-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077802-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077802-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077802-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 51008af2-39ac-546c-e063-6294a90a758f | 2026-05-04 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Coupler LLC | 50873ef7-3deb-7386-e063-6394a90a9c19 | 2026-04-28 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a90cd1f1-5258-4b0e-92fd-c4cebe47772b | 2026-04-06 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | REMEDYREPACK INC. | a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | 2026-02-17 | Warnings, Adverse reactions | 077802 ANDA077802 70518-3237-0 70518-3237 70518323700 |
| Oxcarbazepine | OXCARBAZEPINE | Glenmark Pharmaceuticals Inc., USA | 1c713b59-a628-42e6-b166-ae71c3913284 | 2025-12-03 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Direct_rx | 21b0cc84-b64a-75de-e063-6294a90a9dd0 | 2024-09-09 | Warnings, Adverse reactions | 077802 ANDA077802 |
| Oxcarbazepine | OXCARBAZEPINE | Proficient Rx LP | 95867dcd-fd0e-4570-987b-d35939f7d7d1 | 2022-11-01 | Warnings, Adverse reactions | 077802 ANDA077802 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oxcarbazepine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXCARBAZEPINE | 300 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| VZI5B1W380 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312137 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ca2a6da1-5711-44d0-9e79-c84d4265f98b | Product name | 3 | 20250724 |
| 536d5b6b-66f1-478b-2670-88fd15947e3b | Product name | 7 | 20250218 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3237-0 | Oxcarbazepine | 100 in 1 BOX | TABLET, FILM COATED | 100 | 8 | |
| 70518-3237-1 | Oxcarbazepine | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 8 | |
| 70518-3237-2 | Oxcarbazepine | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3237 | OXCARBAZEPINE TABLET, FILM COATED [REMEDYREPACK INC.] | 5 | Current NDC, Legacy NDC, 3 package rows | 20250215_a2032bcc-2da5-45e5-aa3f-ddbf50909df8.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312137 | OXcarbazepine 300 MG Oral Tablet | PSN | a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | 8 |
| 312137 | oxcarbazepine 300 MG Oral Tablet | SCD | a2032bcc-2da5-45e5-aa3f-ddbf50909df8 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-3237-0 | 70518323700 | 100 POUCH in 1 BOX (70518-3237-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-3237-1) | 100 pouch | 2021-10-13 | 0000-00-00 | No | No | Current |